Pelvic Inflammatory Disease: Pelvic inflammatory disease (PID) is an acute or chronic inflammation in the pelvic cavity. It is most commonly caused by sexually transmitted diseases, including chlamydia and gonorrhea that have ascended into the uterus, fallopian tubes, or ovaries as a result of intercourse or childbirth, or of surgical procedures, including insertion of IUDs or abortion. PID may be either symptomatic or asymptomatic. It may cause infertility and it may raise the risk of ectopic pregnancy. PID is a disease associated with HIV infection.
Female pelvic inflammatory disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
N14_FEMPELINFINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
138 |
4. Check minimum number of eventsNone |
138 |
5. Include endpointsNone |
138 |
6. Filter based on genotype QC (FinnGen only) |
138 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Female pelvic inflammatory disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Inflammatory diseases of female pelvic organs
- Genitourinary diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1114 | 1114 | - |
| Only index persons | 1099 | 1099 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | - |
| Only index persons | 0.04 | 0.04 | - |
| Median age at first event (years) | |||
| Whole population | - | 23.59 | - |
| Only index persons | - | 23.53 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 138 | 138 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 24.91 | 24.91 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 127
- Matched controls
- 1269
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N74.4*A56.1
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
132.6
103
*
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
153.1
33.5
34
*
A56.1
ICD-10 Finland
Chlamydial infection of pelviperitoneum and other genitourinary organs
221.3
19.1
19
*
P01AB01
ATC
metronidazole; oral, rectal
5.7
18.7
87
352
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
5.7
15.5
52
137
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
21.3
13.9
20
11
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.1
12.9
80
373
N70.0
ICD-10 Finland
Acute salpingitis and oophoritis
+∞
12.7
12
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
4.1
12.7
71
301
J01AA02
ATC
doxycycline; systemic
4.9
11.5
109
704
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
+∞
10.6
10
*
N74.4
ICD-10 Finland
Female chlamydial pelvic inflammatory disease
+∞
9.5
9
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.1
8.8
77
418
N76.0
ICD-10 Finland
Acute vaginitis
5.3
8.7
27
61
N71.9
ICD-10 Finland
Inflammatory disease of uterus, unspecified
21.9
8.6
12
6
R51.80
ICD-10 Finland
Headache
3.8
8.6
40
136
N02AX02
ATC
tramadol; systemic, rectal
3.1
7.6
52
233
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
+∞
7.4
7
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
3.5
7.1
37
134
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
3.4
6.9
36
131
J01DB01
ATC
cefalexin; oral
4.1
6.8
115
892
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
3.3
6.8
38
147
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
3.7
6.6
30
99
M77.1
ICD-10 Finland
Lateral epicondylitis
4.5
6.4
22
56
N70.9
ICD-10 Finland
Salpingitis and oophoritis, unspecified
+∞
6.3
6
*
M03BX02
ATC
tizanidine; oral
2.7
6.2
90
604
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
3.6
6.2
28
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
55
247
3.04
8.84
2.1
1.9
u/l
48.2
54.2
1.13
47
232
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
79
440
2.86
8.43
3.6
2.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
42
182
2.88
6.99
3.0
2.3
u/l
2787.7
5545.4
0.40
16
86
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
70
397
2.55
6.78
3.4
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
75
440
2.54
6.75
3.1
4.7
umol/l
8.3
9.0
0.46
67
413
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
47
236
2.50
5.72
2.0
2.2
ng/l
7.1
13.3
2.15
13
74
(3026008) Bacteria identified in Urine by Culture
56
318
2.28
5.08
2.5
2.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
294
2.17
4.34
3.1
2.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
127
1064
3.43
4.12
7.9
6.8
mmol/l
3.9
3.9
0.11
121
1016
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
51
300
2.11
4.08
2.2
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
32
156
2.37
4.03
1.4
1.5
%
1.4
1.3
0.69
26
140
(3023368) Bacteria identified in Blood by Culture
31
149
2.39
4.02
2.1
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
116
2.53
3.95
1.3
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
111
2.53
3.83
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
41
231
2.10
3.62
1.8
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
27
129
2.36
3.53
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
80
574
1.94
3.52
3.9
2.9
estimate
0.0
0.0
0.00
20
118
(3032080) INR in Blood by Coagulation assay
39
219
2.09
3.46
5.1
3.7
inr
1.0
1.0
1.83
15
80
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
10
7.30
3.40
1.0
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
103
812
2.06
3.37
3.2
2.4
u/l
62.5
27.8
0.88
96
784
(3021601) Nitrite [Presence] in Urine by Test strip
79
570
1.90
3.36
5.2
4.0
estimate
0.0
0.0
0.00
21
120
(3015736) pH of Urine
67
461
1.88
3.28
3.2
2.7
—
—
—
0
0
(3013512) EKG study
32
170
2.15
3.26
2.8
2.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
15
5.59
3.24
1.8
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
40
233
2.01
3.19
2.5
2.3
e6/l
0.4
0.3
0.14
29
169
(36304419) Bacteria [Presence] in Urine
41
244
1.97
3.07
2.5
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
42
255
1.93
2.96
2.7
2.4
e6/l
14.4
54.5
0.94
31
185
(40761536) Microorganisms panel - Urine sediment
23
111
2.29
2.93
4.2
2.9
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
116
977
2.17
2.88
4.5
4.6
pmol/l
14.4
14.2
0.47
110
928
(3009261) Glucose [Presence] in Urine by Test strip
78
581
1.79
2.81
3.9
3.0
estimate
0.0
0.0
0.00
22
116
(3029937) Albumin [Presence] in Urine by Test strip
48
310
1.84
2.78
4.1
3.1
estimate
0.0
0.0
0.00
20
119
(4024509)
5
7
7.35
2.57
1.2
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
74
554
1.72
2.53
3.2
3.4
mmol/l
6.3
6.1
0.38
64
464
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
27
3.49
2.44
1.0
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
50
339
1.74
2.42
3.8
2.8
e6/l
90.4
47.5
0.21
31
201
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
8
6.43
2.39
3.4
1.9
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
8
6.43
2.39
1.0
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
129
2.04
2.35
1.8
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
92
741
1.72
2.33
5.0
5.7
u/l
70.1
70.0
0.01
81
699
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
40
257
1.78
2.31
1.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
60
2.48
2.30
2.5
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
48
2.64
2.25
1.3
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
9
5.71
2.23
1.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
9
5.71
2.23
5.0
1.3
%
100.2
136.0
—
5
9
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
62
455
1.66
2.20
3.8
2.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
10
5.14
2.09
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
6
15
4.13
2.06
2.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
116
1015
1.90
2.03
7.2
6.5
ml/min/173m2
99.5
98.7
0.16
94
785
(3041096) Erythrocytes [Presence] in Urine by Automated
50
354
1.65
2.01
3.5
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
11
45
2.57
1.98
1.7
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
218
1.74
1.96
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
129
1190
2.29
1.78
7.7
7.1
u/l
21.2
22.5
0.57
122
1156
(3013707) Erythrocyte sedimentation rate by Westergren method
96
811
1.60
1.76
3.5
3.2
mm/h
7.8
7.8
0.01
87
769
(1616796) Gas panel - Central venous blood
5
13
3.95
1.73
1.8
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
58
439
1.55
1.72
1.9
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
295
1.61
1.71
1.4
1.3
g/l
2.1
2.1
0.00
20
186
(3044640) Blood type and Crossmatch panel - Blood
48
349
1.58
1.69
1.7
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
98
838
1.58
1.64
5.5
3.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
46
333
1.57
1.64
1.3
1.3
u/ml
0.6
1.2
0.97
16
92
(3048689) Calprotectin [Mass/mass] in Stool
29
187
1.70
1.63
1.7
2.5
ug/g
32.8
67.4
1.85
19
144
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
124
1130
1.96
1.60
5.2
5.1
mu/l
1.5
1.6
1.15
115
1080
(3011397) Hemoglobin [Presence] in Urine by Test strip
37
256
1.61
1.59
3.3
3.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
65
2.10
1.54
2.7
3.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
113
1006
1.68
1.54
4.0
3.0
mmol/l
5.4
5.5
0.51
102
951
(3014051) Protein [Presence] in Urine by Test strip
6
21
2.94
1.52
1.5
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
58
449
1.50
1.51
1.8
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
88
1.93
1.49
1.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
16
3.20
1.45
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
60
473
1.48
1.41
2.2
1.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
121
1.76
1.40
2.0
2.1
e6/l
2.3
5.2
—
8
62
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
17
3.01
1.37
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
17
3.01
1.37
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
117
1062
1.67
1.34
3.2
2.9
mmol/l
4.8
4.7
0.58
110
1022
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
112
1007
1.60
1.32
2.8
2.7
mmol/l
1.2
1.1
0.31
106
968
(40761511) CBC panel - Blood by Automated count
133
1261
2.51
1.32
10.5
8.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
63
1.99
1.27
1.7
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
13
71
1.92
1.24
1.5
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
21
134
1.67
1.23
1.7
1.9
e6/l
0.9
1.0
—
9
76
(3022621) pH of Urine by Test strip
12
64
1.96
1.22
2.8
2.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
26
2.37
1.20
4.0
1.8
%
12.8
13.5
—
6
26
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
26
2.37
1.20
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
96
1.75
1.16
1.1
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
104
1.72
1.16
1.0
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
31
2.32
1.12
1.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
130
1.63
1.10
1.5
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
261
1.46
1.06
3.2
2.9
kg/l
1.0
1.0
—
5
42
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
115
1056
1.53
1.06
3.2
2.9
mmol/l
1.5
1.5
0.61
107
1015
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
47
1.98
1.04
1.2
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
99
885
1.42
1.04
4.3
3.5
mmol/mol
37.0
36.5
0.21
91
852
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
116
1.63
1.03
1.4
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
77
1.76
0.99
2.3
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
85
1.72
0.98
1.3
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
17
110
1.62
0.96
1.5
1.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1164
1.64
0.96
11.3
8.2
mg/l
20.2
16.8
0.60
109
861
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
28
2.19
0.92
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
35
268
1.41
0.92
1.7
1.7
mg/l
0.4
0.7
3.15
27
194
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
115
1065
1.48
0.92
3.4
3.0
mmol/l
2.9
2.8
0.32
107
1021
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
70
600
1.34
0.91
3.7
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
41
324
1.38
0.90
2.8
4.3
mmol/l
1.2
1.2
1.33
34
303
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
64
1.78
0.89
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
15
97
1.61
0.85
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
37
291
1.37
0.83
1.9
1.9
mg/l
2.7
2.6
0.06
31
258
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
121
0.56
0.82
1.7
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
48
1.71
0.80
1.3
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
6
33
1.85
0.80
4.2
2.9
mmol/l
1.4
-0.5
—
6
23
(3016879) Cocaine [Presence] in Urine
15
99
1.58
0.79
1.3
1.6
—
—
—
0
0
(3019225) pH of Specimen
11
67
1.70
0.77
3.4
4.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
38
1.89
0.75
2.1
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
40
324
1.33
0.74
3.4
5.0
—
—
—
0
0
(4010399)
10
60
1.72
0.74
1.2
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
39
1.84
0.73
1.3
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
39
1.84
0.73
1.3
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
39
1.84
0.73
2.6
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
39
1.84
0.73
1.3
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
40
1.79
0.72
5.9
1.9
g/l
0.2
0.2
—
7
40
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
85
1.58
0.72
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
27
207
1.38
0.71
1.4
1.3
nmol/l
21.1
22.1
0.11
22
189
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
69
1.65
0.71
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
27
1.88
0.69
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
27
1.88
0.69
1.2
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
120
1.48
0.68
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
129
0.60
0.68
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
44
1.62
0.66
1.3
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
15
104
1.50
0.65
1.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
15
104
1.50
0.65
1.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
42
349
1.29
0.65
1.5
1.7
pmol/l
96.4
95.2
0.06
23
201
(3007853) Bacteria identified in Skin by Aerobe culture
16
113
1.47
0.64
1.7
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
239
1.33
0.62
1.4
1.3
iu/ml
9.5
36.3
—
8
62
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
194
1.35
0.61
1.2
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
35
1.75
0.58
5.5
2.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
73
1.55
0.58
1.2
1.3
ug/l
3.3
2.9
0.17
11
68
(3024561) Albumin [Mass/volume] in Serum or Plasma
39
326
1.27
0.57
3.4
3.6
g/l
37.0
37.6
0.29
33
308
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.65
0.56
1.2
2.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
37
1.65
0.56
5.8
1.8
%
116.2
147.5
—
6
37
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
75
1.51
0.52
1.3
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
75
1.51
0.52
1.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
40
1.52
0.52
1.7
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
43
370
1.24
0.49
3.4
5.1
mmol/l
1.2
1.2
1.24
34
322
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
82
0.60
0.47
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
103
1.40
0.47
1.4
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
11
77
1.47
0.47
4.8
4.0
mmol/l
1.0
1.0
0.03
11
71
(3037522) Nuclear Ab [Titer] in Serum
22
175
1.31
0.47
1.6
1.4
titre
193.3
526.2
—
6
26
(3015377) Calcium [Moles/volume] in Serum or Plasma
35
296
1.24
0.47
2.3
2.6
mmol/l
2.4
2.3
0.37
30
271
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
151
0.70
0.46
1.5
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
71
648
1.20
0.45
3.8
7.3
e9/l
4.6
3.9
1.81
64
571
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
118
1132
1.29
0.44
4.8
4.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
8
55
1.48
0.44
1.1
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
87
1.42
0.44
1.4
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
31
1.64
0.43
1.2
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
8
57
1.43
0.43
1.4
1.6
nmol/l
0.4
0.5
—
8
47
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
246
1.23
0.38
1.5
1.5
mmol/l
1.8
1.3
0.41
24
222
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
22
181
1.26
0.37
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
22
181
1.26
0.37
1.1
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
57
517
1.17
0.37
3.9
4.8
%
3.1
2.7
0.49
50
491
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
41
1.48
0.36
1.3
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
26
219
1.23
0.36
2.3
3.0
ph
7.4
7.4
—
9
35
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
51
459
1.18
0.36
2.0
2.2
nmol/l
72.2
72.2
0.00
46
439
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
42
1.45
0.36
1.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
22
182
1.25
0.36
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
22
182
1.25
0.36
1.1
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
57
519
1.17
0.35
4.3
5.0
%
7.2
7.6
0.56
51
495
(21494755) Public health laboratory ask at order entry panel
16
198
0.78
0.35
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
119
1150
1.25
0.35
9.9
9.4
%
40.0
39.5
0.93
95
984
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
46
1.32
0.33
1.0
1.0
—
9.9
—
0
9
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
53
1.34
0.31
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
242
1.20
0.31
1.3
1.3
u/ml
1.0
8.0
—
9
106
(3002030) Lymphocytes/100 leukocytes in Blood
59
545
1.14
0.29
4.1
4.8
%
30.3
30.5
0.06
52
523
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
87
1.29
0.25
1.0
1.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
5
38
1.33
0.23
1.0
2.0
kpa
5.3
5.1
—
5
38
(1761868) Lipid panel - Serum or Plasma
49
453
1.13
0.23
2.6
2.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
503
1.12
0.22
1.8
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
41
1.23
0.22
1.6
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
5
42
1.20
0.21
1.0
2.0
kpa
6.0
5.6
—
5
42
(4027681)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
59
554
1.11
0.21
4.0
5.2
e9/l
0.5
0.5
0.43
52
504
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
3.8
—
15.0
—
0
12
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
53
495
1.11
0.21
3.8
4.9
%
0.7
0.6
0.25
47
464
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
14.9
—
1008.9
—
0
14
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
21.9
—
1913.0
—
0
14
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
242
1.14
0.20
1.5
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
59
558
1.10
0.18
4.0
5.1
e9/l
0.0
0.0
0.46
53
503
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
82
1.24
0.17
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
141
0.84
0.17
2.0
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
52
490
1.10
0.17
7.5
6.8
e9/l
0.0
0.0
0.00
43
407
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
172
0.86
0.17
1.9
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
151
0.85
0.16
1.2
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
150
0.85
0.15
1.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
103
1.18
0.14
1.2
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
62
598
1.07
0.10
2.4
2.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
56
539
1.07
0.10
3.8
4.6
%
56.6
55.9
0.17
50
515
(3000494) Fungus identified in Specimen by Culture
12
106
1.14
0.10
1.6
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
45
1.12
0.10
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
45
1.12
0.10
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(4035726)
5
61
0.81
0.08
1.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
14
153
0.91
0.07
1.2
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
9
83
1.09
0.07
2.0
1.7
mg/l
5.7
2.7
—
9
56
(3020682) Albumin/Creatinine [Ratio] in Urine
18
167
1.09
0.07
4.2
4.4
mg/mmol
2.6
13.0
1.85
11
114
(3008898) HLA-B27 [Presence]
8
93
0.85
0.07
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
108
1093
0.95
0.06
11.1
10.8
g/l
332.5
332.2
0.12
108
1087
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
327
1.05
0.05
1.4
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
258
1.06
0.05
3.9
5.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
46
473
0.96
0.05
1.9
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
130
0.92
0.05
2.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
310
0.96
0.03
3.3
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
261
1.04
0.03
1.4
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
17
162
1.06
0.02
3.0
3.5
mg/l
31.2
73.7
0.87
11
112
(3003694) ABO and Rh group [Type] in Blood
50
506
0.98
0.00
1.9
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
167
1.02
0.00
1.2
1.3
iu/ml
334.7
158.6
—
5
70
(3044889) 12 lead EKG panel
60
603
0.99
0.00
2.7
2.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4281824)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
1.2
—
0
6
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
23.3
—
0
7
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
1.8
—
12.1
—
0
5
(1175426) CD3 cells/100 lymphocytes in Blood
0
8
0.00
0.00
0.0
1.3
—
77.9
—
0
8
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
7
0.00
0.00
0.0
1.0
—
27.4
—
0
7
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.8
—
1.8
—
0
6
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
81.0
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
6
0.00
0.00
0.0
1.0
—
30.8
—
0
6
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
2.3
—
4.9
—
0
6
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.5
—
0
7
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
6.1
—
0
5
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
1.4
—
91.6
—
0
7
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
1.5
—
0
8
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.2
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
22
220
1.00
0.00
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
24.5
—
0
6
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
58
0.86
0.00
1.6
2.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
6.2
—
0
5
(3006245) CD3-CD19+ cells/100 cells in Blood
0
8
0.00
0.00
0.0
1.4
—
10.1
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint N14_FEMPELINFINOTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_FEMPELINFINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_FEMPELINFINOTH – Female pelvic inflammatory disorders in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data